CPL-500036

N/A

Report date: 2024/07/16 10:59:33
NME

Base Information

Drug NameCPL-500036
Drug Alias NameCPL500036CPL'36CPL-500-036-02CZ20PG203 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 10A inhibitors
TargetsPhosphodiesterase 10A
Therapy Area/IndicationsSchizophreniaDyskinesia, Drug-InducedParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkrainePolandHungary
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelon Pharma Sa
China Registration ClassN/A

Develop Information

Active CompaniesCelon Pharma Sa
Inactive CompaniesN/A
Active IndicationsSchizophreniaDyskinesia, Drug-InducedParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A